Eintrag weiter verarbeiten
Dental caries vaccine: are we there yet?
Gespeichert in:
| Zeitschriftentitel: | Letters in Applied Microbiology |
|---|---|
| Personen und Körperschaften: | |
| In: | Letters in Applied Microbiology, 70, 2020, 1, S. 2-12 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Oxford University Press (OUP)
|
| Schlagwörter: |
| author_facet |
Patel, M. Patel, M. |
|---|---|
| author |
Patel, M. |
| spellingShingle |
Patel, M. Letters in Applied Microbiology Dental caries vaccine: are we there yet? Applied Microbiology and Biotechnology |
| author_sort |
patel, m. |
| spelling |
Patel, M. 1472-765X 0266-8254 Oxford University Press (OUP) Applied Microbiology and Biotechnology http://dx.doi.org/10.1111/lam.13218 <jats:sec> <jats:title>Abstract</jats:title> <jats:p>Dental caries, caused by Streptococcus mutans, is a common infection. Caries vaccine has been under investigation for the last 40 years. Many in vitro and in vivo studies and some human clinical trials have determined many pertinent aspects regarding vaccine development. The virulence determinants of Strep. mutans, such as Ag I/II, responsible for adherence to surfaces, glucosyltransferase, responsible for the production of glucan, and the glucan-binding protein, responsible for the attachment of glucan to surfaces, have been known to elicit an antigen-specific immune response. It is also known that more than one antigen or a functional part of the genome responsible for these virulence determinants provide a better host response compared with the monogenic vaccine or complete genome of a specific antigen. To enhance the host response, the use of adjuvants has been studied and the routes of antigen administration have been investigated. In recent years, some promising vaccines such as pGJA-P/VAX, LT derivative/Pi39-512, KFD2-rPAc and SBR/GBR-CMV-nirB have been developed and tested in animals. New virulence targets need to be explored. Multicentre collaborative studies and human clinical trials are required and some interest from funders and public health experts should be generated to overcome this hurdle.</jats:p> </jats:sec> <jats:sec> <jats:title>Significance and Impact of the Study</jats:title> <jats:p>Dental caries is an irreversible, multifactorial opportunistic infection. The treatment is costly, making it a public health problem. Despite many years of promising laboratory research, animal studies and clinical trials, there is no commercially available vaccine today. The research objectives have become more refined from lessons learnt over the years. Multigenic DNA/recombinant vaccines, using the best proved adjuvants with a delivery system for the nasal or sublingual route, should be developed and researched with multicentre collaborative efforts. In addition, new vaccine targets can be identified. To overcome the economic hurdle, funders and public health interest should be stimulated.</jats:p> </jats:sec> Dental caries vaccine: are we there yet? Letters in Applied Microbiology |
| doi_str_mv |
10.1111/lam.13218 |
| facet_avail |
Online Free |
| finc_class_facet |
Biologie Technik |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9sYW0uMTMyMTg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9sYW0uMTMyMTg |
| institution |
DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 |
| imprint |
Oxford University Press (OUP), 2020 |
| imprint_str_mv |
Oxford University Press (OUP), 2020 |
| issn |
1472-765X 0266-8254 |
| issn_str_mv |
1472-765X 0266-8254 |
| language |
English |
| mega_collection |
Oxford University Press (OUP) (CrossRef) |
| match_str |
patel2020dentalcariesvaccinearewethereyet |
| publishDateSort |
2020 |
| publisher |
Oxford University Press (OUP) |
| recordtype |
ai |
| record_format |
ai |
| series |
Letters in Applied Microbiology |
| source_id |
49 |
| title |
Dental caries vaccine: are we there yet? |
| title_unstemmed |
Dental caries vaccine: are we there yet? |
| title_full |
Dental caries vaccine: are we there yet? |
| title_fullStr |
Dental caries vaccine: are we there yet? |
| title_full_unstemmed |
Dental caries vaccine: are we there yet? |
| title_short |
Dental caries vaccine: are we there yet? |
| title_sort |
dental caries vaccine: are we there yet? |
| topic |
Applied Microbiology and Biotechnology |
| url |
http://dx.doi.org/10.1111/lam.13218 |
| publishDate |
2020 |
| physical |
2-12 |
| description |
<jats:sec>
<jats:title>Abstract</jats:title>
<jats:p>Dental caries, caused by Streptococcus mutans, is a common infection. Caries vaccine has been under investigation for the last 40 years. Many in vitro and in vivo studies and some human clinical trials have determined many pertinent aspects regarding vaccine development. The virulence determinants of Strep. mutans, such as Ag I/II, responsible for adherence to surfaces, glucosyltransferase, responsible for the production of glucan, and the glucan-binding protein, responsible for the attachment of glucan to surfaces, have been known to elicit an antigen-specific immune response. It is also known that more than one antigen or a functional part of the genome responsible for these virulence determinants provide a better host response compared with the monogenic vaccine or complete genome of a specific antigen. To enhance the host response, the use of adjuvants has been studied and the routes of antigen administration have been investigated. In recent years, some promising vaccines such as pGJA-P/VAX, LT derivative/Pi39-512, KFD2-rPAc and SBR/GBR-CMV-nirB have been developed and tested in animals. New virulence targets need to be explored. Multicentre collaborative studies and human clinical trials are required and some interest from funders and public health experts should be generated to overcome this hurdle.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Significance and Impact of the Study</jats:title>
<jats:p>Dental caries is an irreversible, multifactorial opportunistic infection. The treatment is costly, making it a public health problem. Despite many years of promising laboratory research, animal studies and clinical trials, there is no commercially available vaccine today. The research objectives have become more refined from lessons learnt over the years. Multigenic DNA/recombinant vaccines, using the best proved adjuvants with a delivery system for the nasal or sublingual route, should be developed and researched with multicentre collaborative efforts. In addition, new vaccine targets can be identified. To overcome the economic hurdle, funders and public health interest should be stimulated.</jats:p>
</jats:sec> |
| container_issue |
1 |
| container_start_page |
2 |
| container_title |
Letters in Applied Microbiology |
| container_volume |
70 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792344429531496449 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:07:26.226Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Dental+caries+vaccine%3A+are+we+there+yet%3F&rft.date=2020-01-01&genre=article&issn=0266-8254&volume=70&issue=1&spage=2&epage=12&pages=2-12&jtitle=Letters+in+Applied+Microbiology&atitle=Dental+caries+vaccine%3A+are+we+there+yet%3F&aulast=Patel&aufirst=M.&rft_id=info%3Adoi%2F10.1111%2Flam.13218&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792344429531496449 |
| author | Patel, M. |
| author_facet | Patel, M., Patel, M. |
| author_sort | patel, m. |
| container_issue | 1 |
| container_start_page | 2 |
| container_title | Letters in Applied Microbiology |
| container_volume | 70 |
| description | <jats:sec> <jats:title>Abstract</jats:title> <jats:p>Dental caries, caused by Streptococcus mutans, is a common infection. Caries vaccine has been under investigation for the last 40 years. Many in vitro and in vivo studies and some human clinical trials have determined many pertinent aspects regarding vaccine development. The virulence determinants of Strep. mutans, such as Ag I/II, responsible for adherence to surfaces, glucosyltransferase, responsible for the production of glucan, and the glucan-binding protein, responsible for the attachment of glucan to surfaces, have been known to elicit an antigen-specific immune response. It is also known that more than one antigen or a functional part of the genome responsible for these virulence determinants provide a better host response compared with the monogenic vaccine or complete genome of a specific antigen. To enhance the host response, the use of adjuvants has been studied and the routes of antigen administration have been investigated. In recent years, some promising vaccines such as pGJA-P/VAX, LT derivative/Pi39-512, KFD2-rPAc and SBR/GBR-CMV-nirB have been developed and tested in animals. New virulence targets need to be explored. Multicentre collaborative studies and human clinical trials are required and some interest from funders and public health experts should be generated to overcome this hurdle.</jats:p> </jats:sec> <jats:sec> <jats:title>Significance and Impact of the Study</jats:title> <jats:p>Dental caries is an irreversible, multifactorial opportunistic infection. The treatment is costly, making it a public health problem. Despite many years of promising laboratory research, animal studies and clinical trials, there is no commercially available vaccine today. The research objectives have become more refined from lessons learnt over the years. Multigenic DNA/recombinant vaccines, using the best proved adjuvants with a delivery system for the nasal or sublingual route, should be developed and researched with multicentre collaborative efforts. In addition, new vaccine targets can be identified. To overcome the economic hurdle, funders and public health interest should be stimulated.</jats:p> </jats:sec> |
| doi_str_mv | 10.1111/lam.13218 |
| facet_avail | Online, Free |
| finc_class_facet | Biologie, Technik |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9sYW0uMTMyMTg |
| imprint | Oxford University Press (OUP), 2020 |
| imprint_str_mv | Oxford University Press (OUP), 2020 |
| institution | DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15 |
| issn | 1472-765X, 0266-8254 |
| issn_str_mv | 1472-765X, 0266-8254 |
| language | English |
| last_indexed | 2024-03-01T17:07:26.226Z |
| match_str | patel2020dentalcariesvaccinearewethereyet |
| mega_collection | Oxford University Press (OUP) (CrossRef) |
| physical | 2-12 |
| publishDate | 2020 |
| publishDateSort | 2020 |
| publisher | Oxford University Press (OUP) |
| record_format | ai |
| recordtype | ai |
| series | Letters in Applied Microbiology |
| source_id | 49 |
| spelling | Patel, M. 1472-765X 0266-8254 Oxford University Press (OUP) Applied Microbiology and Biotechnology http://dx.doi.org/10.1111/lam.13218 <jats:sec> <jats:title>Abstract</jats:title> <jats:p>Dental caries, caused by Streptococcus mutans, is a common infection. Caries vaccine has been under investigation for the last 40 years. Many in vitro and in vivo studies and some human clinical trials have determined many pertinent aspects regarding vaccine development. The virulence determinants of Strep. mutans, such as Ag I/II, responsible for adherence to surfaces, glucosyltransferase, responsible for the production of glucan, and the glucan-binding protein, responsible for the attachment of glucan to surfaces, have been known to elicit an antigen-specific immune response. It is also known that more than one antigen or a functional part of the genome responsible for these virulence determinants provide a better host response compared with the monogenic vaccine or complete genome of a specific antigen. To enhance the host response, the use of adjuvants has been studied and the routes of antigen administration have been investigated. In recent years, some promising vaccines such as pGJA-P/VAX, LT derivative/Pi39-512, KFD2-rPAc and SBR/GBR-CMV-nirB have been developed and tested in animals. New virulence targets need to be explored. Multicentre collaborative studies and human clinical trials are required and some interest from funders and public health experts should be generated to overcome this hurdle.</jats:p> </jats:sec> <jats:sec> <jats:title>Significance and Impact of the Study</jats:title> <jats:p>Dental caries is an irreversible, multifactorial opportunistic infection. The treatment is costly, making it a public health problem. Despite many years of promising laboratory research, animal studies and clinical trials, there is no commercially available vaccine today. The research objectives have become more refined from lessons learnt over the years. Multigenic DNA/recombinant vaccines, using the best proved adjuvants with a delivery system for the nasal or sublingual route, should be developed and researched with multicentre collaborative efforts. In addition, new vaccine targets can be identified. To overcome the economic hurdle, funders and public health interest should be stimulated.</jats:p> </jats:sec> Dental caries vaccine: are we there yet? Letters in Applied Microbiology |
| spellingShingle | Patel, M., Letters in Applied Microbiology, Dental caries vaccine: are we there yet?, Applied Microbiology and Biotechnology |
| title | Dental caries vaccine: are we there yet? |
| title_full | Dental caries vaccine: are we there yet? |
| title_fullStr | Dental caries vaccine: are we there yet? |
| title_full_unstemmed | Dental caries vaccine: are we there yet? |
| title_short | Dental caries vaccine: are we there yet? |
| title_sort | dental caries vaccine: are we there yet? |
| title_unstemmed | Dental caries vaccine: are we there yet? |
| topic | Applied Microbiology and Biotechnology |
| url | http://dx.doi.org/10.1111/lam.13218 |